NCT07926711Phase 4Recruiting
Comparative Effectiveness of Intralesional Injection of Triamcinolone Acetonide vs. Microneedling With Local Application of Triamcinolone Acetonide in the Treatment of Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 4
- Sponsor
- Dow University of Health Sciences
- Participants (registry)
- 276
- Start
- January 2026
- Primary completion
- December 2026 (planned)
- Study completion
- December 2026 (planned)
- Last registry update
- November 2026
- Countries
- Pakistan
Conditions studied: Alopecia Areata
Interventions: Triamcinolone acetonide, Microneedling with topical triamcinolone acetonide
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.